REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc.

Biotechnology Healthcare San Diego, CA, United States REVBW (NCM)

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has REVELATION BIOSCIENCES, INC. had layoffs?
No layoff events have been recorded for REVELATION BIOSCIENCES, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does REVELATION BIOSCIENCES, INC. have?
REVELATION BIOSCIENCES, INC. has approximately 8 employees.
What industry is REVELATION BIOSCIENCES, INC. in?
REVELATION BIOSCIENCES, INC. operates in the Biotechnology industry, within the Healthcare sector.
Is REVELATION BIOSCIENCES, INC. a publicly traded company?
Yes, REVELATION BIOSCIENCES, INC. is publicly traded under the ticker symbol REVBW on the NCM.
Where is REVELATION BIOSCIENCES, INC. headquartered?
REVELATION BIOSCIENCES, INC. is headquartered in San Diego, CA, United States at 4660 La Jolla Village Drive, San Diego, CA 92122, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.